Julia G. Butchko, Chief Development Officer at Immunovant, Inc. (IMVT), sold 6,406 shares at $32.75 ($210K) on 2023-11-22, disclosed to the SEC on 2023-11-24.
Open-market sale of $210k IMVT by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.75 | 3,141 | $103K | 49.0% |
| 2 | $32.75 | 3,141 | $103K | 49.0% |
| 3 | $33.52 | 124 | $4K | 2.0% |
| Total | $32.76 avg | 6,406 | $210K | 100% |
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |